跳至主要内容
临床试验/NCT02376192
NCT02376192已完成4 期

Maternal Microcirculation & SDF Imaging: A Novel Assessment of the Microcirculation During Cesarean Delivery With Spinal Anesthesia and the Impact of Phenylephrine Prophylaxis to Prevent Spinal Anesthesia-induced Hypotension.

IWK Health Centre1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
32
试验地点
1
主要终点
Microvascular Flow Index (MFI)

研究概览

简要总结

This is a study of pregnant women undergoing a cesarean delivery. It will compare their microcirculation before and after the anesthetic. Microcirculation means blood flow to the extremely small blood vessels in the body. It will also look at the differences in microcirculation of participants who receive an infusion of phenylephrine compared to participants who don't. The investigators hypothesize that spinal anesthesia will reduce the vascular density and proportion of perfused vessels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) Physical Status I-II (ASA I - Healthy, ASA II - mild and controlled systemic disease)
  • Singleton pregnancies
  • 36-42 weeks gestation
  • Non-labouring
  • Scheduled cesarean delivery
  • English speaking
  • Age 18-45 years

排除标准

  • Cardiovascular disease
  • Hypertensive disease of pregnancy (i.e. mild & severe preeclampsia)
  • Allergy to phenylephrine, or any other standardized medication
  • Obesity (BMI > 35 kg/m2)
  • Diabetes Mellitus type 1
  • Coffee/Caffeine intake within 6 hours of SDF measurement

研究组 & 干预措施

Bolus Phenylephrine/Ephedrine Treatment'

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants who experience hypotension will receive bolus phenylephrine and/or ephedrine treatment as needed.

干预措施: Initial MicroScan® (Microvision Medical) SDF Measurement (Device)

Bolus Phenylephrine/Ephedrine Treatment'

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants who experience hypotension will receive bolus phenylephrine and/or ephedrine treatment as needed.

干预措施: Spinal Anesthesia- Bupivacaine (Drug)

Bolus Phenylephrine/Ephedrine Treatment'

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants who experience hypotension will receive bolus phenylephrine and/or ephedrine treatment as needed.

干预措施: Comparative MicroScan® (Microvision Medical) SDF Measurement (Device)

Bolus Phenylephrine/Ephedrine Treatment'

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants who experience hypotension will receive bolus phenylephrine and/or ephedrine treatment as needed.

干预措施: Bolus Phenylephrine/Ephedrine Treatment (Drug)

Phenylephrine Infusion Group

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants will have an infusion of phenylephrine started immediately following the induction of spinal anesthesia for prevention of hypotension.

干预措施: Initial MicroScan® (Microvision Medical) SDF Measurement (Device)

Phenylephrine Infusion Group

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants will have an infusion of phenylephrine started immediately following the induction of spinal anesthesia for prevention of hypotension.

干预措施: Spinal Anesthesia- Bupivacaine (Drug)

Phenylephrine Infusion Group

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants will have an infusion of phenylephrine started immediately following the induction of spinal anesthesia for prevention of hypotension.

干预措施: Comparative MicroScan® (Microvision Medical) SDF Measurement (Device)

Phenylephrine Infusion Group

Experimental

Initial MicroScan® (Microvision Medical) SDF measurement are recorded in the obstetric preoperative area within two hours prior to administration of spinal anesthesia. In the operating room participants will receive a standard spinal anesthetic (hyperbaric bupivacaine, fentanyl and preservative free morphine) followed by a second comparative MicroScan® (Microvision Medical) SDF measurement within 10 minutes of initiation of spinal anesthetic. Participants will have an infusion of phenylephrine started immediately following the induction of spinal anesthesia for prevention of hypotension.

干预措施: Phenylephrine Infusion (Drug)

结局指标

主要结局

Microvascular Flow Index (MFI)

时间窗: Immediately prior to, and within 10 minutes of induction of spinal anesthesia

The change in MFI of participants; measured immediately prior to, and within 10 minutes following the induction of spinal anesthesia

次要结局

  • Microvascular Flow Index (MFI)(Immediately prior to, and within 10 minutes of induction of spinal anesthesia)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronald George

Director of Medical Research

IWK Health Centre

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Study for maternal and fetal circulation in perinatal periodpregnancy
JPRN-UMIN000030566Toho University Omori Medical Center1,500
已完成
不适用
Parturient MicrocirculationPregnancyMicrocirculation
NCT01491685IWK Health Centre36
Unknown
不适用
Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical ChorioamnionitisChorioamnionitis
NCT00299637Hadassah Medical Organization34
进行中(未招募)
不适用
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10
招募中
不适用
Visualizing uterine microvasculature using contrast-enhanced ultrasound for differentiating between uteri with adenomyosis, myoma, sarcoma, and no uterine disordersadenomyosisgrowth of inner lining uterus into uterine wall10038595
NL-OMON56469Amsterdam UMC223
Maternal Microcirculation & SDF Imaging | 临床试验